In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...
A new study has revealed that GLP-1 drugs, commonly used for diabetes and weight loss, show promise in treating alcohol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback